CIK 0001615219 · Non-accelerated filer<br>Smaller reporting company
Decoy Therapeutics Inc.
Sign in to watch- Ticker
- DCOY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 465087339
- Phone
- 346-772-0346
- Business address
- 2450 HOLCOMBE BLVD, SUITE J-608, HOUSTON, TX, 77021
- Former names
- Salarius Pharmaceuticals, Inc., Flex Pharma, Inc.
- 4/A Grant or award Exec VP Finance, CFO acquired 7,314 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 10,000 shares (grant or award)
- 4 Grant or award Exec VP Finance, CFO acquired 7,314 shares (grant or award)
- 8-K Event Other events
- 8-K Event Other events
- 8-K Event Other events
- 8-K Event Bylaws or fiscal year change
- EFFECT Other Notice of Effectiveness
- 8-K Event Results of operations
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- 10-Q Report Quarterly Report
- 8-K Event Other events
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 8-K Event Shareholder vote results
- S-3 Offering Registration Statement
- 4 Open-market buy Director bought 27,700 shares at $0.18 ($4,986)
Page 11 of 38 · 744 filings